GeneDx Holdings Stock-Based Compensation 2020-2023 | WGS
GeneDx Holdings stock-based compensation from 2020 to 2023. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| GeneDx Holdings Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2023 | $-0 |
| 2022 | $42 |
| 2021 | $219 |
| 2020 | $120 |
| 2019 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.553B | $0.203B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.503B | 15.75 |
| Cencora (COR) | United States | $44.240B | 17.25 |
| ICON (ICLR) | Ireland | $26.547B | 25.06 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Avantor (AVTR) | United States | $17.124B | 25.21 |
| CochLear (CHEOY) | Australia | $14.770B | 0.00 |
| Revvity (RVTY) | United States | $13.241B | 23.23 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.178B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.576B | 41.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.562B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 22.93 |
| Solventum (SOLV) | United States | $10.784B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.628B | 0.00 |
| HealthEquity (HQY) | United States | $6.508B | 48.62 |
| Organon (OGN) | United States | $5.568B | 5.28 |
| Bausch + Lomb (BLCO) | Canada | $5.269B | 21.11 |
| Doximity (DOCS) | United States | $4.449B | 33.12 |
| PACS (PACS) | United States | $4.257B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.440B | 31.48 |
| Sotera Health (SHC) | United States | $3.230B | 15.85 |
| Life Times (LTH) | United States | $2.979B | 31.21 |
| GoodRx Holdings (GDRX) | United States | $2.728B | 103.86 |
| Progyny (PGNY) | United States | $2.550B | 43.90 |
| Premier (PINC) | United States | $2.383B | 8.92 |
| AMN Healthcare Services Inc (AMN) | United States | $2.287B | 9.06 |
| NovoCure (NVCR) | Jersey | $2.265B | 0.00 |
| Agilon Health (AGL) | United States | $2.180B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.992B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.647B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.348B | 0.00 |
| Embecta (EMBC) | United States | $0.793B | 5.39 |
| CareDx (CDNA) | United States | $0.770B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.690B | 7.32 |
| Auna S.A (AUNA) | Luxembourg | $0.648B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.566B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.456B | 0.00 |
| Enhabit (EHAB) | United States | $0.434B | 43.30 |
| MultiPlan (MPLN) | United States | $0.405B | 0.00 |
| ModivCare (MODV) | United States | $0.382B | 7.15 |
| LifeMD (LFMD) | United States | $0.351B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 18.67 |
| Beauty Health (SKIN) | United States | $0.342B | 0.00 |
| Sharecare (SHCR) | United States | $0.275B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.124B | 41.67 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| Oncology Institute (TOI) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 6.84 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |